Open AccessImpact of Prescriber Nonresponse on Patient Representativeness
Author(s) -
Annie FourrierRéglat,
C. Droz–Perroteau,
Jacques Bénichou,
F. Depont,
M Amouretti,
Bernard Bégaud,
Yola Moride,
Patrick Blin,
Nicholas Moore
Publication year - 2008
Publication title -
epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.901
H-Index - 173
eISSN - 1531-5487
pISSN - 1044-3983
DOI - 10.1097/ede.0b013e31816326e9
Subject(s) - medicine , rofecoxib , pharmacoepidemiology , medical prescription , celecoxib , concomitant , emergency medicine , pharmacology , biochemistry , chemistry , cyclooxygenase , enzyme
In pharmacoepidemiology studies where patients are selected by prescribers, there is concern that the patients of responding prescribers are not necessarily an unbiased sample of all patients. However, this usually cannot be explored. In the CADEUS study, patients and prescribers were independently contacted so that data are available for patients irrespective of whether their prescriber responded or not. Our objective was to compare the characteristics of patients whose prescriber did or did not respond.